Skin mesenchymal niches maintain and protect AML-initiating stem cells

Author:

Sandhow Lakshmi12ORCID,Cai Huan12ORCID,Leonard Elory12ORCID,Xiao Pingnan12ORCID,Tomaipitinca Luana12ORCID,Månsson Alma12ORCID,Kondo Makoto12ORCID,Sun Xiaoyan3ORCID,Johansson Anne-Sofie12ORCID,Tryggvason Karl4ORCID,Kasper Maria3ORCID,Järås Marcus5ORCID,Qian Hong12ORCID

Affiliation:

1. Center for Hematology and Regenerative Medicine, Karolinska Institute 1 Department of Medicine Huddinge, , , Stockholm, Sweden

2. Karolinska University Hospital 1 Department of Medicine Huddinge, , , Stockholm, Sweden

3. Karolinska Institute 2 Department of Cell and Molecular Biology, , Stockholm, Sweden

4. Karolinska Institute 3 Department of Medical Biochemistry and Biophysics, , Stockholm, Sweden

5. Lund University 4 Department of Clinical Genetics, , Lund, Sweden

Abstract

Leukemia cutis or leukemic cell infiltration in skin is one of the common extramedullary manifestations of acute myeloid leukemia (AML) and signifies a poorer prognosis. However, its pathogenesis and maintenance remain understudied. Here, we report massive AML cell infiltration in the skin in a transplantation-induced MLL-AF9 AML mouse model. These AML cells could regenerate AML after transplantation. Prospective niche characterization revealed that skin harbored mesenchymal progenitor cells (MPCs) with a similar phenotype as BM mesenchymal stem cells. These skin MPCs protected AML-initiating stem cells (LSCs) from chemotherapy in vitro partially via mitochondrial transfer. Furthermore, Lama4 deletion in skin MPCs promoted AML LSC proliferation and chemoresistance. Importantly, more chemoresistant AML LSCs appeared to be retained in Lama4−/− mouse skin after cytarabine treatment. Our study reveals the characteristics and previously unrecognized roles of skin mesenchymal niches in maintaining and protecting AML LSCs during chemotherapy, meriting future exploration of their impact on AML relapse.

Funder

Swedish Research Council

Swedish Childhood Cancer Foundation

Swedish Cancer Foundation

Dr Åke Olsson Foundation

Radiumhemmets Forskningsfonder

Karolinska Institute Wallenberg Institute for Regenerative Medicine

Karolinska Institute

Stiftelsen Clas Groschinskys Minnesfond

Cancer Research Karolinska Institute

Incyte Biosciences Nordic

Knut and Alice Wallenberg Foundation

Publisher

Rockefeller University Press

Subject

Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3